US Stock MarketDetailed Quotes

Marker Therapeutics (MRKR)

Watchlist
  • 1.450
  • -0.090-5.84%
Close Apr 23 16:00 ET
  • 1.450
  • 0.0000.00%
Post 16:10 ET
24.18MMarket Cap-1.84P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marker Therapeutics (MRKR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.86%12.44M
-51.21%1.88M
-10.97%2.14M
84.61%4.26M
63.03%4.16M
-23.75%11.12M
31.44%3.86M
-25.01%2.4M
-44.17%2.31M
-40.85%2.55M
Selling and administrative expenses
-1.34%4.18M
-17.56%846.61K
19.79%1.02M
-17.23%945.16K
12.41%1.37M
-43.26%4.24M
-25.42%1.03M
-39.50%854.68K
-54.66%1.14M
-43.80%1.22M
-General and administrative expense
-1.34%4.18M
-17.56%846.61K
19.79%1.02M
-17.23%945.16K
12.41%1.37M
-43.26%4.24M
-25.42%1.03M
-39.50%854.68K
-54.66%1.14M
-43.80%1.22M
Research and development costs
-12.39%11.8M
-57.91%2.14M
-32.42%2.35M
78.86%4.18M
21.76%3.14M
29.29%13.47M
94.33%5.09M
69.74%3.47M
-1.79%2.34M
-23.74%2.58M
Other operating expenses
46.19%-3.55M
51.00%-1.1M
35.99%-1.23M
26.35%-861.18K
71.94%-349.1K
-99.06%-6.59M
-113.13%-2.25M
-647.66%-1.93M
-53.31%-1.17M
-0.79%-1.24M
Operating profit
-11.86%-12.44M
51.21%-1.88M
10.97%-2.14M
-84.61%-4.26M
-63.03%-4.16M
1.35%-11.12M
-1,134.28%-3.86M
25.01%-2.4M
44.17%-2.31M
40.85%-2.55M
Net non-operating interest income expense
35.97%594.21K
124.59%165.63K
50.59%138.06K
10.95%128.03K
4.03%162.49K
-18.95%437.01K
-63.37%73.75K
-57.96%91.68K
228.93%115.39K
84.51%156.2K
Non-operating interest income
35.97%594.21K
124.59%165.63K
50.59%138.06K
10.95%128.03K
4.03%162.49K
-18.95%437.01K
-63.37%73.75K
-57.96%91.68K
228.93%115.39K
84.51%156.2K
Other net income (expense)
-335.69K
0
117.44K
-453.14K
Special income (charges)
---453.14K
--0
--0
--0
---453.14K
--0
--0
--0
--0
--0
-Less:Other special charges
--453.14K
--0
----
----
--453.14K
----
----
----
----
----
Other non- operating income (expenses)
--117.44K
--0
----
--117.44K
----
----
----
----
----
----
Income before tax
-14.02%-12.18M
54.63%-1.72M
13.41%-2M
-83.14%-4.02M
-85.81%-4.45M
0.46%-10.68M
-759.09%-3.79M
22.59%-2.31M
46.51%-2.19M
43.36%-2.39M
Income tax
-130.34%-15.16K
1,259.27%49.95K
Net income
-13.35%-12.16M
55.62%-1.7M
13.41%-2M
-83.14%-4.02M
-85.81%-4.45M
-30.28%-10.73M
-36.91%-3.84M
22.59%-2.31M
-187.16%-2.19M
51.83%-2.39M
Net income continuous Operations
-13.35%-12.16M
55.62%-1.7M
13.41%-2M
-83.14%-4.02M
-85.81%-4.45M
23.60%-10.73M
-40.05%-3.84M
22.59%-2.31M
46.51%-2.19M
43.36%-2.39M
Net income discontinuous operations
----
----
----
----
----
--0
--0
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-13.35%-12.16M
55.62%-1.7M
13.41%-2M
-83.14%-4.02M
-85.81%-4.45M
-30.28%-10.73M
-36.91%-3.84M
22.59%-2.31M
-187.16%-2.19M
51.83%-2.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-13.35%-12.16M
55.62%-1.7M
13.41%-2M
-83.14%-4.02M
-85.81%-4.45M
-30.28%-10.73M
-36.91%-3.84M
22.59%-2.31M
-187.16%-2.19M
51.83%-2.39M
Basic earnings per share
33.61%-0.79
90.48%-0.04
53.85%-0.12
-16.00%-0.29
-48.15%-0.4
-26.60%-1.19
-31.25%-0.42
23.53%-0.26
-186.21%-0.25
52.63%-0.27
Diluted earnings per share
33.61%-0.79
90.48%-0.04
53.85%-0.12
-16.00%-0.29
-48.15%-0.4
-26.60%-1.19
-31.25%-0.42
23.53%-0.26
-186.21%-0.25
52.63%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.86%12.44M-51.21%1.88M-10.97%2.14M84.61%4.26M63.03%4.16M-23.75%11.12M31.44%3.86M-25.01%2.4M-44.17%2.31M-40.85%2.55M
Selling and administrative expenses -1.34%4.18M-17.56%846.61K19.79%1.02M-17.23%945.16K12.41%1.37M-43.26%4.24M-25.42%1.03M-39.50%854.68K-54.66%1.14M-43.80%1.22M
-General and administrative expense -1.34%4.18M-17.56%846.61K19.79%1.02M-17.23%945.16K12.41%1.37M-43.26%4.24M-25.42%1.03M-39.50%854.68K-54.66%1.14M-43.80%1.22M
Research and development costs -12.39%11.8M-57.91%2.14M-32.42%2.35M78.86%4.18M21.76%3.14M29.29%13.47M94.33%5.09M69.74%3.47M-1.79%2.34M-23.74%2.58M
Other operating expenses 46.19%-3.55M51.00%-1.1M35.99%-1.23M26.35%-861.18K71.94%-349.1K-99.06%-6.59M-113.13%-2.25M-647.66%-1.93M-53.31%-1.17M-0.79%-1.24M
Operating profit -11.86%-12.44M51.21%-1.88M10.97%-2.14M-84.61%-4.26M-63.03%-4.16M1.35%-11.12M-1,134.28%-3.86M25.01%-2.4M44.17%-2.31M40.85%-2.55M
Net non-operating interest income expense 35.97%594.21K124.59%165.63K50.59%138.06K10.95%128.03K4.03%162.49K-18.95%437.01K-63.37%73.75K-57.96%91.68K228.93%115.39K84.51%156.2K
Non-operating interest income 35.97%594.21K124.59%165.63K50.59%138.06K10.95%128.03K4.03%162.49K-18.95%437.01K-63.37%73.75K-57.96%91.68K228.93%115.39K84.51%156.2K
Other net income (expense) -335.69K0117.44K-453.14K
Special income (charges) ---453.14K--0--0--0---453.14K--0--0--0--0--0
-Less:Other special charges --453.14K--0----------453.14K--------------------
Other non- operating income (expenses) --117.44K--0------117.44K------------------------
Income before tax -14.02%-12.18M54.63%-1.72M13.41%-2M-83.14%-4.02M-85.81%-4.45M0.46%-10.68M-759.09%-3.79M22.59%-2.31M46.51%-2.19M43.36%-2.39M
Income tax -130.34%-15.16K1,259.27%49.95K
Net income -13.35%-12.16M55.62%-1.7M13.41%-2M-83.14%-4.02M-85.81%-4.45M-30.28%-10.73M-36.91%-3.84M22.59%-2.31M-187.16%-2.19M51.83%-2.39M
Net income continuous Operations -13.35%-12.16M55.62%-1.7M13.41%-2M-83.14%-4.02M-85.81%-4.45M23.60%-10.73M-40.05%-3.84M22.59%-2.31M46.51%-2.19M43.36%-2.39M
Net income discontinuous operations ----------------------0--0--0--0--0
Minority interest income
Net income attributable to the parent company -13.35%-12.16M55.62%-1.7M13.41%-2M-83.14%-4.02M-85.81%-4.45M-30.28%-10.73M-36.91%-3.84M22.59%-2.31M-187.16%-2.19M51.83%-2.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -13.35%-12.16M55.62%-1.7M13.41%-2M-83.14%-4.02M-85.81%-4.45M-30.28%-10.73M-36.91%-3.84M22.59%-2.31M-187.16%-2.19M51.83%-2.39M
Basic earnings per share 33.61%-0.7990.48%-0.0453.85%-0.12-16.00%-0.29-48.15%-0.4-26.60%-1.19-31.25%-0.4223.53%-0.26-186.21%-0.2552.63%-0.27
Diluted earnings per share 33.61%-0.7990.48%-0.0453.85%-0.12-16.00%-0.29-48.15%-0.4-26.60%-1.19-31.25%-0.4223.53%-0.26-186.21%-0.2552.63%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.81%
Sample Name
Sample Code
 +16.13%
Sample Name
Sample Code
 +12.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+11.25%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.06%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.80%
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +8.01%
4
Chagee Holdings
CHA
+5.92%
5
Taiwan Semiconductor
TSM
+5.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -